{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:00:10Z","timestamp":1761879610408,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.rxeng.2021.03.001","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T14:34:24Z","timestamp":1654180464000},"page":"12-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases"],"prefix":"10.1016","volume":"65","author":[{"given":"P.","family":"Oliv\u00e1n-Sasot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"P\u00e9rez-Enguix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bello-Arques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Torres-Espallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Falg\u00e1s-Lacueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Yepes-Agudelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Olivas-Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rxeng.2021.03.001_bib0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL\u2013EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.rxeng.2021.03.001_bib0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1200\/JOP.2017.022996","article-title":"Medical management of hepatocellular carcinoma","volume":"13","author":"Rich","year":"2017","journal-title":"J Oncol Pract."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.medcli.2016.01.028","article-title":"Diagn\u00f3stico y tratamiento del carcinoma hepatocelular. Actualizaci\u00f3n del documento de consenso de la AEEH, SEOM, SERAM, SERVEI y SETH","volume":"146","author":"Forner","year":"2016","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.12972","article-title":"Treatment options for unresectable HCC with a focus on SIRT with Yttrium\u201090 resin microspheres","volume":"71","author":"Wang","year":"2017","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0030","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.21037\/hbsn.2018.10.06","article-title":"The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future","volume":"7","author":"Sposito","year":"2018","journal-title":"Hepatobiliary Surg Nutr."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0040","first-page":"329","article-title":"Downstaging de carcinoma hepatocelular bilobar tras radioembolizaci\u00f3n con microesferas de 90 Y como puente al trasplante hep\u00e1tico","volume":"36","author":"Reguera-Berenguer","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2967\/jnumed.108.058347","article-title":"SPECT\/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer","volume":"50","author":"Hamami","year":"2009","journal-title":"J Nucl Med."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0050","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00270-016-1310-9","article-title":"Radioembolization: is prophylactic embolization of hepaticoenteric arteries necessary? A systematic review","volume":"39","author":"Borggreve","year":"2016","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0055","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","article-title":"Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours","volume":"23","author":"Ho","year":"1996","journal-title":"Eur J Nucl Med."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0060","first-page":"1","article-title":"Post-radioembolization yttrium-90 PET\/CT - part 1: diagnostic reporting","volume":"3","author":"Kao","year":"2013","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0065","unstructured":"Version 5.0. Common Terminology Criteria for Adverse Events (CTCAE). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf (4\/8\/2020)."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0070","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00259-013-2395-x","article-title":"Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept","volume":"40","author":"Garin","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0075","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00270-018-2008-y","article-title":"Radioembolization super survivors: extended survival in non-operative hepatocellular carcinoma","volume":"41","author":"Gordon","year":"2018","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0080","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.2147\/OTT.S137519","article-title":"Yttrium-90 radioembolization of unresectable hepatocellular carcinoma - a single center experience","volume":"10","author":"Meyer","year":"2017","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0085","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"Hilgard","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0095","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2009.07.006","article-title":"Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma","volume":"77","author":"I\u00f1arrairaegui","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0032-1329906","article-title":"Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions","volume":"32","author":"Bolondi","year":"2013","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0105","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0110","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.rxeng.2021.03.001_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2967\/jnumed.111.094235","article-title":"Dosimetry based on 99mTc-macroaggregated albumin SPECT\/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results","volume":"53","author":"Garin","year":"2012","journal-title":"J Nucl Med."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0120","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2017.12.026","article-title":"Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion","volume":"68","author":"Spreafico","year":"2018","journal-title":"J Hepatol."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0125","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/cncr.23339","article-title":"Liver disease induced by radioembolization of liver tumors","volume":"112","author":"Sangro","year":"2008","journal-title":"Cancer."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0130","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.26191","article-title":"Prognostic factors and prevention of radioembolization-induced liver disease","volume":"57","author":"Gil-Alzugaray","year":"2013","journal-title":"Hepatology."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0135","first-page":"244","article-title":"Radioembolizaci\u00f3n de tumores hep\u00e1ticos con 90Y-microesferas","volume":"34","author":"Rodr\u00edguez-Fraile","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0140","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 Radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rxeng.2021.03.001_bib0145","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00259-018-3968-5","article-title":"Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies","volume":"45","author":"Sangro","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Radiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173510721000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173510721000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T02:17:14Z","timestamp":1761877034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173510721000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2173510721000501"],"URL":"https:\/\/doi.org\/10.1016\/j.rxeng.2021.03.001","relation":{},"ISSN":["2173-5107"],"issn-type":[{"type":"print","value":"2173-5107"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases","name":"articletitle","label":"Article Title"},{"value":"Radiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rxeng.2021.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rx.2020.09.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SERAM. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}